In 2026, Provigil (modafinil) remains the definitive therapeutic choice for the treatment of excessive daytime sleepiness. While often grouped with classic stimulants like caffeine or amphetamines, Provigil is technically a "eugeroic"—a wakefulness-promoting agent—that offers a smoother, more targeted alert state without the physical "edge" or significant crash of traditional stimulants.